Tufton Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.6M Sell
53,500
-738
-1% -$172K 2.28% 9
2026
Q1
$13.3M Sell
54,238
-777
-1% -$181K 2.41% 12
2025
Q4
$11.4M Sell
55,015
-348
-0.6% -$68.8K 1.99% 15
2025
Q3
$10.3M Buy
55,363
+177
+0.3% +$30.3K 1.83% 15
2025
Q2
$8.43M Sell
55,186
-2,096
-4% -$322K 1.6% 24
2025
Q1
$9.5M Buy
57,282
+177
+0.3% +$27.7K 1.83% 17
2024
Q4
$8.26M Buy
57,105
+171
+0.3% +$26.5K 1.56% 25
2024
Q3
$9.23M Sell
56,934
-1,550
-3% -$247K 1.73% 22
2024
Q2
$8.55M Buy
58,484
+993
+2% +$148K 1.66% 24
2024
Q1
$9.09M Sell
57,491
-168
-0.3% -$26.7K 1.79% 21
2023
Q4
$9.04M Sell
57,659
-175
-0.3% -$26.8K 1.9% 17
2023
Q3
$9.01M Sell
57,834
-72
-0.1% -$11.9K 2.01% 12
2023
Q2
$9.58M Sell
57,906
-1,039
-2% -$168K 2.07% 13
2023
Q1
$9.14M Sell
58,945
-2,276
-4% -$368K 1.98% 17
2022
Q4
$10.8M Buy
61,221
+1,649
+3% +$285K 2.38% 11
2022
Q3
$9.73M Sell
59,572
-17,880
-23% -$3.03M 2.35% 10
2022
Q2
$13.7M Sell
77,452
-552
-0.7% -$98.4K 2.57% 11
2022
Q1
$13.8M Sell
78,004
-987
-1% -$168K 2.23% 12
2021
Q4
$13.5M Buy
78,991
+535
+0.7% +$87.6K 2.07% 13
2021
Q3
$12.7M Sell
78,456
-659
-0.8% -$112K 2.14% 12
2021
Q2
$13M Sell
79,115
-1,220
-2% -$202K 2.14% 12
2021
Q1
$13.2M Buy
80,335
+834
+1% +$135K 2.26% 13
2020
Q4
$12.5M Buy
79,501
+1,005
+1% +$148K 2.31% 13
2020
Q3
$11.7M Sell
78,496
-1,009
-1% -$149K 2.41% 11
2020
Q2
$11.2M Sell
79,505
-264
-0.3% -$38.5K 2.46% 12
2020
Q1
$10.5M Sell
79,769
-250
-0.3% -$35.5K 2.68% 8
2019
Q4
$11.7M Buy
80,019
+2,049
+3% +$278K 2.3% 15
2019
Q3
$10.1M Sell
77,970
-418
-0.5% -$55.1K 2.13% 15
2019
Q2
$10.9M Sell
78,388
-510
-0.6% -$70.6K 2.31% 11
2019
Q1
$11M Sell
78,898
-4,112
-5% -$551K 2.35% 12
2018
Q4
$10.7M Sell
83,010
-60
-0.1% -$8.37K 2.63% 5
2018
Q3
$11.5M Sell
83,070
-5,188
-6% -$689K 2.44% 10
2018
Q2
$10.7M Buy
88,258
+382
+0.4% +$47.7K 2.3% 8
2018
Q1
$11.3M Buy
87,876
+2,447
+3% +$331K 2.22% 8
2017
Q4
$11.9M Sell
85,429
-623
-0.7% -$86.8K 2.3% 7
2017
Q3
$11.2M Buy
86,052
+10
+0% +$1.33K 2.24% 10
2017
Q2
$11.4M Sell
86,042
-3,065
-3% -$391K 2.31% 8
2017
Q1
$11.1M Sell
89,107
-615
-0.7% -$73.5K 2.19% 9
2016
Q4
$10.3M Sell
89,722
-1,751
-2% -$202K 2.1% 11
2016
Q3
$10.8M Buy
91,473
+25
+0% +$3.03K 2.18% 10
2016
Q2
$11.1M Sell
91,448
-2,429
-3% -$276K 2.25% 6
2016
Q1
$10.2M Buy
93,877
+207
+0.2% +$21.4K 2.53% 9
2015
Q4
$9.62M Sell
93,670
-1,702
-2% -$171K 2.37% 9
2015
Q3
$8.9M Sell
95,372
-3,217
-3% -$311K 1.96% 11
2015
Q2
$9.61M Sell
98,589
-7,979
-7% -$799K 1.94% 12
2015
Q1
$10.7M Buy
106,568
+1,185
+1% +$121K 1.97% 11
2014
Q4
$11M Sell
105,383
-3,097
-3% -$326K 2.01% 12
2014
Q3
$11.6M Sell
108,480
-1,375
-1% -$143K 2.17% 9
2014
Q2
$11.5M Buy
109,855
+792
+0.7% +$80.1K 2.33% 5
2014
Q1
$10.7M Sell
109,063
-185
-0.2% -$17.2K 2.24% 8
2013
Q4
$10M Sell
109,248
-1,493
-1% -$138K 2.14% 8
2013
Q3
$9.6M Sell
110,741
-1,226
-1% -$110K 2.26% 9
2013
Q2
$9.61M Buy
+111,967
New +$9.5M 2.31% 8

Other funds holding JNJ

Tufton Capital Management's JNJ Position: Q2 2026 in Review

Tufton Capital Management reduced its Johnson & Johnson (JNJ) stake by 1.4% in Q2 2026, selling an estimated $172K and leaving 53,500 shares worth $13.6M. The position accounts for 2.28% of the portfolio, ranked #9.

Tufton Capital Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.8M in Q1 2022. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Tufton Capital Management held 53,500 shares of Johnson & Johnson worth $13.6M as of Q2 2026.
  • Tufton Capital Management sold 738 Johnson & Johnson shares in Q2 2026, an estimated $172K.
  • Johnson & Johnson made up 2.28% of Tufton Capital Management's portfolio in Q2 2026, its #9 holding.
  • Tufton Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Tufton Capital Management's Johnson & Johnson position peaked at $13.8M in Q1 2022.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Tufton Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.